The global advanced dermatology drug delivery devices market size was US$ 3,569.9 million in 2021. The global advanced dermatology drug delivery devices market size is forecast to reach US$ 8,785.0 ...
Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...
Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...
Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress ...
Abstract: Microarray chip technology has met the challenges of traditional fluorescent labeling in terms of high cost and low detection efficiency , and provides a high-throughput and cost-effective ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass.--(BUSINESS WIRE) ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research Thermo Fisher Scientific, the ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback